Alma D. Blanco-Chavez

Tlalpan, CP
Mexico, MEX 14080, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Polypharmacy, polypharmacology, and polypharmacotherapy: clarifying definitions and complementary roles in cancer treatment - a narrative review.

Polypharmacy, polypharmacology, and polypharmacotherapy: clarifying definitions and complementary roles in cancer treatment - a narrative review.

Journal: Expert review of anticancer therapy

Published: May 30, 2026

Expression of Hexokinase-2 (HK2), Glutaminase-1 (GLS1) and Fatty Acid Synthase (FASN) in Gastric Cancer and Their Prognostic Significance.

Expression of Hexokinase-2 (HK2), Glutaminase-1 (GLS1) and Fatty Acid Synthase (FASN) in Gastric Cancer and Their Prognostic Significance.

Journal: Medical sciences (Basel, Switzerland)

Published: February 14, 2026

In Silico Molecular Docking Analysis of Valproic Acid as an Inhibitor of Bruton's Tyrosine Kinase: Potential Drug Repurposing for Allergies.

In Silico Molecular Docking Analysis of Valproic Acid as an Inhibitor of Bruton's Tyrosine Kinase: Potential Drug Repurposing for Allergies.

Journal: Cureus

Published: August 17, 2025

Epigenetic reprogramming of mast and cancer cells modifies tumor-promoting cytokine networks.

Epigenetic reprogramming of mast and cancer cells modifies tumor-promoting cytokine networks.

Journal: Medical oncology (Northwood, London, England)

Published: April 29, 2025

Metabolic reprogramming and synergistic cytotoxicity of genistein and chemotherapy in human breast cancer cells.

Metabolic reprogramming and synergistic cytotoxicity of genistein and chemotherapy in human breast cancer cells.

Journal: Life sciences

Published: December 10, 2024

Mast Cell Carboxypeptidase A3 Is Associated with Pulmonary Fibrosis Secondary to COVID-19.

Mast Cell Carboxypeptidase A3 Is Associated with Pulmonary Fibrosis Secondary to COVID-19.

Journal: International journal of molecular sciences

Published: October 15, 2024

Pharmacokinetics and pharmacodynamics of angiogenesis inhibitors used to treat cervical cancer: current and future.

Pharmacokinetics and pharmacodynamics of angiogenesis inhibitors used to treat cervical cancer: current and future.

Journal: Expert opinion on drug metabolism & toxicology

Published: September 10, 2024

Impaired control of Mycobacterium tuberculosis infection in mast cell-deficient KitW-sh/W-sh mice.

Impaired control of Mycobacterium tuberculosis infection in mast cell-deficient KitW-sh/W-sh mice.

Journal: Tuberculosis (Edinburgh, Scotland)

Published: June 26, 2024

Multitargeted polypharmacotherapy for cancer treatment. theoretical concepts and proposals.

Multitargeted polypharmacotherapy for cancer treatment. theoretical concepts and proposals.

Journal: Expert review of anticancer therapy

Published: June 24, 2024

N-(2-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Induces Apoptosis and Cell Cycle Arrest in Breast Cancer Cells, Decreasing GPER Expression.

N-(2-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Induces Apoptosis and Cell Cycle Arrest in Breast Cancer Cells, Decreasing GPER Expression.

Journal: Molecules (Basel, Switzerland)

Published: April 16, 2024

The inhibitory and transcriptional effects of the epigenetic repurposed drugs hydralazine and valproate in lymphoma cells.

The inhibitory and transcriptional effects of the epigenetic repurposed drugs hydralazine and valproate in lymphoma cells.

Journal: American journal of cancer research

Published: February 29, 2024

Mast cell activation signature as a potential biomarker in COVID-19.

Mast cell activation signature as a potential biomarker in COVID-19.

Journal: Immunology letters

Published: February 08, 2024

Showing 1-12 of 58

Last Updated: 09/26/2026